FTO, the pioneering demethylase acknowledged for its recognition of m6A, has been implicated in human diseases, notably breast cancer, by fostering cell proliferation and metastasis, as evidenced in both in vitro and in vivo studies (Niu et al. 2019). Here, MBD2 is linked to breast carcinoma.